Bipolar Disorder Therapeutics Global Market Report 2022: Increase in the Prevalence of Bipolar Disorder to Drive Growth - ResearchAndMarkets.com
The "Bipolar Disorder Therapeutics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering
DUBLIN--(BUSINESS WIRE)--Sep 13, 2022--
The "Bipolar Disorder Therapeutics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
The global bipolar disorder therapeutics market is expected to grow from $6.00 billion in 2021 to $6.47 billion in 2022 at a compound annual growth rate (CAGR) of 7.8%. The bipolar disorder therapeutics market is expected to grow to $7.67 billion in 2026 at a CAGR of 4.4%.
North America was the largest region in the bipolar disorder therapeutics market in 2021. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the bipolar disorder therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
